BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 07, 2008
 |  BioCentury  |  Finance

New products to watch

New products to watch

Company Product Indication Location
Acambis (LSE:ACM) ACAM2000 Prevent smallpox in subjects at high risk of exposure U.S.
Actelion (SWX:ATLN) Tracleer bosentan Reduce the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease EU
Alexion (NASDAQ:ALXN) Soliris eculizumab Paroxysmal nocturnal hemoglobinuria (PNH) U.S./EU
Amgen (NASDAQ:AMGN) Vectibix panitumumab EGFR-expressing metastatic colorectal cancer with wild-type K-ras (KRAS) genes after failure of standard chemotherapy EU
Anesiva (NASDAQ:ANSV) Zingo needle-free injection of lidocaine powder Pain associated with venous access procedures in children ages 3-18 U.S.
BioMarin (NASDAQ:BMRN; SWX:BMRN) Kuvan sapropterin Phenylketonuria (PKU) U.S.
Celgene (NASDAQ:CELG) Revlimid lenalidomide In combination with dexamethasone for multiple myeloma...

Read the full 698 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >